Parkinson’s Disease

If you have a loved one who is suffering from Parkinson’s Disease, you are aware of the associated inflammation issues that can occur in the brain.

While it has long been believed that this inflammation is a result of Parkinson’s Disease, over the last few years, inflammation has actually been viewed as causing the progressive nature of the disease.

This means that those with early onset Parkinson’s Disease may be able to reduce most symptoms through the reduction of inflammation.

At the Helen Foundation, we have studied the effects of inflammation on the body for years and have created an effective solution to reduce inflammation of Parkinson’s Disease.

Through hydrocortisone microdosing, those battling moderate to severe Parkinson’s Disease saw 62% average movement improvement and 67% average mental improvement in our extensive study. By comparison, Levodopa averages 7-29% movement improvement and 0% mental improvement.

This high rate of success comes from our microdosing techniques that ask patients to only take hydrocortisone on the bad days of their inflammation, and not on the good ones.

Hydrocortisone is produced naturally in the body to reduce inflammation, but this production can dip as we age. When administered properly, a hydrocortisone microdose will increase hydrocortisone up to the required levels to arrest inflammation with no side effects. This method is so effective in fact, that medical doctors use it on themselves to reduce inflammation in their own bodies.

Should you believe microdose therapy for Parkinson’s Disease is right for you or a family member, and you would like to learn more, we are standing by to help you gain a better understanding of our microdosing techniques.

As you begin your microdosing journey our team will measure your Parkinson’s disease’s severity daily, offer prescriptions from doctors by telemedicine and provide an easy-to-understand Patient Education Manual.

Give us a call today at (480) 734-8525 with any questions you may have and be sure to consult your primary doctor so they can participate in these treatments.